CUE BIOPHARMA INC. - COMMON STOCK

Cue Biopharma Announces Upcoming Scientific Presentations at the Society for Immunotherapy of Cancer’s (SITC) 39th Annual Meeting

04 Oct 2024 09:00:00 By Nasdaq GlobeNewswire

Cue Biopharma Announces Pricing of $12.0 Million Public Offering

26 Sep 2024 23:26:30 By Nasdaq GlobeNewswire

Cue Biopharma Announces Proposed Public Offering

26 Sep 2024 23:10:15 By Nasdaq GlobeNewswire

Cue Biopharma Announces Proposed Public Offering

26 Sep 2024 16:27:02 By Nasdaq GlobeNewswire

Cue Biopharma Appoints Industry Veteran Lucinda Warren as Chief Business Officer

09 Sep 2024 08:00:00 By Nasdaq GlobeNewswire

Cue Biopharma to Present at The Promise of Interleukin-2 Therapy Conference

03 Sep 2024 08:00:00 By Nasdaq GlobeNewswire

Cue Biopharma Reports Second Quarter 2024 Financial Results and Recent Business Highlights

19 Aug 2024 16:05:00 By Nasdaq GlobeNewswire

Cue Biopharma to Host Business Update Call and Webcast

13 Aug 2024 08:00:01 By Nasdaq GlobeNewswire

Cue Biopharma Announces Strategic Prioritization of Autoimmune Programs Enabling Optimization of Workforce and Reduction of Capital Requirements

25 Jul 2024 16:05:00 By Nasdaq GlobeNewswire

Cue Biopharma Presents Updated Data from Phase 1 Trial of CUE-101 in Recurrent/Metastatic HPV+ Head and Neck Cancer at the 2024 ASCO Annual Meeting

04 Jun 2024 08:00:00 By Nasdaq GlobeNewswire

Cue Biopharma to Present at Two Upcoming Investor Healthcare Conferences in June 2024

03 Jun 2024 08:00:00 By Nasdaq GlobeNewswire

Cue Biopharma Reports First Quarter 2024 Financial Results and Recent Business Highlights

09 May 2024 16:05:01 By Nasdaq GlobeNewswire

Cue Biopharma to Present at the 20th Annual PEGS Boston Summit

08 May 2024 08:00:00 By Nasdaq GlobeNewswire

Cue Biopharma to Participate in Fireside Chat at The Citizens JMP Life Sciences Conference

07 May 2024 08:00:00 By Nasdaq GlobeNewswire

Cue Biopharma to Present at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

24 Apr 2024 10:01:00 By Nasdaq GlobeNewswire

Cue Biopharma Reports Fourth Quarter and Full Year 2023 Financial Results and Updated Business Highlights

08 Apr 2024 16:05:00 By Nasdaq GlobeNewswire

Cue Biopharma to Host Business Update Call and Webcast

02 Apr 2024 08:00:00 By Nasdaq GlobeNewswire

Cue Biopharma’s Lead Clinical Asset, CUE-101, to be Featured at the 2024 Multi-disciplinary Head and Neck Cancers Symposium

29 Feb 2024 10:00:00 By Nasdaq GlobeNewswire

Cue Biopharma to Present Corporate Update at the Oppenheimer 34th Annual Healthcare Life Sciences Conference

06 Feb 2024 08:00:00 By Nasdaq GlobeNewswire

Cue Biopharma to Present at the JMP Securities Hematology and Oncology Summit

22 Nov 2023 08:00:00 By Nasdaq GlobeNewswire